Related Experiment Video
Updated: Jan 13, 2026
10:10
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
1.8K
[Limbal diseases]
T Streit1, K Ullrich1, G Geerling1
1Klinik für Augenheilkunde, Universitätsklinikum Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Die Ophthalmologie
|January 7, 2026
Summary
The limbus is vital for ocular surface health, housing stem cells for corneal regeneration. This review covers diagnosing and treating limbal diseases, which can impair vision if stem cell deficiency occurs.
Area of Science:
- Ophthalmology
- Stem Cell Biology
- Corneal Science
Background:
- The limbus is crucial for ocular surface health and corneal epithelial regeneration.
- Limbal diseases encompass a range of neoplastic, degenerative, immunological, infectious, and hereditary conditions.
- Severe cases can lead to limbal stem cell deficiency, impairing corneal regeneration and visual acuity.
Purpose of the Study:
- To review diagnostic procedures for limbal diseases.
- To outline current treatment options for limbal diseases.
- To provide a comprehensive overview of limbal stem cell deficiency management.
Main Methods:
- Literature review of diagnostic techniques.
- Synthesis of treatment strategies for various limbal pathologies.
- Analysis of the impact of limbal stem cell deficiency on vision.
Main Results:
- Diagnostic methods vary based on the specific limbal disease.
- Treatment approaches range from topical medications to surgical interventions.
- Early diagnosis and intervention are key to preserving visual function.
Conclusions:
- Effective management of limbal diseases requires accurate diagnosis and tailored treatment.
- Understanding limbal stem cell function is critical for addressing deficiency.
- Further research into novel therapeutic strategies is warranted.
Related Concept Videos
01:22Photoreceptors and Visual Pathways
8.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.7K
01:25Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
01:28Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
01:27Open Angle Glaucoma: Treatment
953
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
953